Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP248239.RA9dVAok-iiRiKjb1miYGbgqnJswxhSvvjtR60P2kH9G8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP248239.RA9dVAok-iiRiKjb1miYGbgqnJswxhSvvjtR60P2kH9G8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP248239.RA9dVAok-iiRiKjb1miYGbgqnJswxhSvvjtR60P2kH9G8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP248239.RA9dVAok-iiRiKjb1miYGbgqnJswxhSvvjtR60P2kH9G8130_provenance.
- NP248239.RA9dVAok-iiRiKjb1miYGbgqnJswxhSvvjtR60P2kH9G8130_assertion description "[Preexposure of the glioma cell lines to the cytokines, IFN gamma and TNF alpha, which sensitize for Fas/APO-1-dependent killing, partially overcame bcl-2-mediated rescue from apoptosis, suggesting that multimodality immunotherapy involving cytokines and Fas/APO-1 targeting might eventually provide a promising approach to the treatment of human malignant gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP248239.RA9dVAok-iiRiKjb1miYGbgqnJswxhSvvjtR60P2kH9G8130_provenance.
- NP248239.RA9dVAok-iiRiKjb1miYGbgqnJswxhSvvjtR60P2kH9G8130_assertion evidence source_evidence_literature NP248239.RA9dVAok-iiRiKjb1miYGbgqnJswxhSvvjtR60P2kH9G8130_provenance.
- NP248239.RA9dVAok-iiRiKjb1miYGbgqnJswxhSvvjtR60P2kH9G8130_assertion SIO_000772 7539458 NP248239.RA9dVAok-iiRiKjb1miYGbgqnJswxhSvvjtR60P2kH9G8130_provenance.
- NP248239.RA9dVAok-iiRiKjb1miYGbgqnJswxhSvvjtR60P2kH9G8130_assertion wasDerivedFrom befree-20150227 NP248239.RA9dVAok-iiRiKjb1miYGbgqnJswxhSvvjtR60P2kH9G8130_provenance.
- NP248239.RA9dVAok-iiRiKjb1miYGbgqnJswxhSvvjtR60P2kH9G8130_assertion wasGeneratedBy ECO_0000203 NP248239.RA9dVAok-iiRiKjb1miYGbgqnJswxhSvvjtR60P2kH9G8130_provenance.
- befree-20150227 importedOn "2015-02-27" NP248239.RA9dVAok-iiRiKjb1miYGbgqnJswxhSvvjtR60P2kH9G8130_provenance.